1 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow cedazuridine: new trials by email Literature Review of cedazuridine trials Research Report on cedazuridine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) Azacitidine, ASTX030 (cedazuridine + azacitidine), Cedazuridine - Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 2 / Phase 3 | Recruiting | Taiho Oncology, Inc. | 316 | 2020-05-21 | 2026-10-06 |
| Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML ASTX727, Dacogen - Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | Phase 3 | Completed | Astex Pharmaceuticals, Inc. | 227 | 2018-02-15 | 2024-08-27 |
Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Chronic (2) · Myelodysplastic Syndromes (2) · Anemia, Refractory, with Excess of Blasts (1) · Hematologic Diseases (1) · Leukemia (1)
Astex Pharmaceuticals, Inc. (1) · Taiho Oncology, Inc. (1)
Canada (2) · Czechia (2) · France (2) · Germany (2) · Hungary (2) · Italy (2) · Spain (2) · United Kingdom (2) · United States (2) · Austria (1) · Poland (1)
2018 (1)